NCT06486012

Brief Summary

This is an investigator-initiated clinical study to establish easy referral and access for diabetic patients from primary health care to oral health care facilities for preventive oral care, periodontal assessment, and treatment, and to investigate the impact of regular home use of aPDT medical device on plaque control and gingival health, when used as an adjunct treatment to standard oral hygiene, and the effect on diabetes control in patients with the risk of periodontal disease, compared to a standard home care oral hygiene regimen.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for not_applicable diabetes-mellitus-type-2

Timeline
31mo left

Started Jan 2025

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Jan 2025Dec 2028

First Submitted

Initial submission to the registry

June 26, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 3, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

January 23, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

2.9 years

First QC Date

June 26, 2024

Last Update Submit

August 5, 2025

Conditions

Keywords

periodontitisdiabetesT2DaPDTaMMP-8

Outcome Measures

Primary Outcomes (1)

  • Bleeding on probing (BOP)

    Change in bleeding on probing (BOP) A full-mouth assessment at six sites per tooth (mesiobuccal, buccal, distobuccal, mesiolingual, lingual, distolingual) Gingival bleeding is considered as positive if bleeding occurs within 15 seconds after gentle probing with a probe at the sulcus Dichotomous scoring to each site of the tooth as bleeding "1 present" and "0 absent" BOP is reported as the percentage (%) of sites with positive findings Calculation formula: number of bleeding sites/ 6 times number of teeth

    12 months

Secondary Outcomes (13)

  • Visual Plaque Index (VPI)

    6 months

  • Visual Plaque Index (VPI)

    12 months

  • Periodontal Pocket Depth (PPD)

    6 months

  • Periodontal Pocket Depth (PPD)

    12 months

  • Clinical Attachment Level (CAL)

    6 months

  • +8 more secondary outcomes

Study Arms (2)

Study group

EXPERIMENTAL

Standard oral hygiene and home-use of Lumoral Treatment aPDT device.

Device: Lumoral TreatmentOther: Standard oral hygiene

Control group

ACTIVE COMPARATOR

Standard oral hygiene

Other: Standard oral hygiene

Interventions

Photodynamic antibacterial dual-light device home-use with a marker substance

Study group

Standard oral hygiene performed at home

Control groupStudy group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diabetic patient treated at community health care;
  • At least 18 years old;
  • Presence of ≥20 teeth;
  • Agreement to participate in the study, and to sign a written consent form;
  • Ability to cooperate with the treatment protocol according to coordinator investigator's assessment.

You may not qualify if:

  • Oral thrush;
  • Known sensitivity to near-infrared or antibacterial blue light.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wellbeing Services of County Pirkanmaa

Tampere, Pirkanmaa, 33520, Finland

RECRUITING

Related Publications (8)

  • Ahmad R, Haque M. Oral Health Messiers: Diabetes Mellitus Relevance. Diabetes Metab Syndr Obes. 2021 Jul 1;14:3001-3015. doi: 10.2147/DMSO.S318972. eCollection 2021.

    PMID: 34234496BACKGROUND
  • Choi SE, Sima C, Pandya A. Impact of Treating Oral Disease on Preventing Vascular Diseases: A Model-Based Cost-effectiveness Analysis of Periodontal Treatment Among Patients With Type 2 Diabetes. Diabetes Care. 2020 Mar;43(3):563-571. doi: 10.2337/dc19-1201. Epub 2019 Dec 27.

    PMID: 31882408BACKGROUND
  • Gasner NS, Schure RS. Periodontal Disease. 2025 May 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554590/

    PMID: 32119477BACKGROUND
  • Kononen E, Gursoy M, Gursoy UK. Periodontitis: A Multifaceted Disease of Tooth-Supporting Tissues. J Clin Med. 2019 Jul 31;8(8):1135. doi: 10.3390/jcm8081135.

    PMID: 31370168BACKGROUND
  • Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):72-80.

    PMID: 28539867BACKGROUND
  • Liccardo D, Cannavo A, Spagnuolo G, Ferrara N, Cittadini A, Rengo C, Rengo G. Periodontal Disease: A Risk Factor for Diabetes and Cardiovascular Disease. Int J Mol Sci. 2019 Mar 20;20(6):1414. doi: 10.3390/ijms20061414.

    PMID: 30897827BACKGROUND
  • Pakarinen S, Saarela RKT, Valimaa H, Heikkinen AM, Kankuri E, Noponen M, Alapulli H, Tervahartiala T, Raisanen IT, Sorsa T, Patila T. Home-Applied Dual-Light Photodynamic Therapy in the Treatment of Stable Chronic Periodontitis (HOPE-CP)-Three-Month Interim Results. Dent J (Basel). 2022 Nov 2;10(11):206. doi: 10.3390/dj10110206.

    PMID: 36354651BACKGROUND
  • Salminen A, Maatta AM, Mantyla P, Leskela J, Pietiainen M, Buhlin K, Suominen AL, Paju S, Sattler W, Sinisalo J, Pussinen PJ. Systemic Metabolic Signatures of Oral Diseases. J Dent Res. 2024 Jan;103(1):13-21. doi: 10.1177/00220345231203562. Epub 2023 Nov 15.

    PMID: 37968796BACKGROUND

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Glucose IntolerancePeriodontal DiseasesPeriodontitisDiabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemiaMouth DiseasesStomatognathic Diseases

Study Officials

  • Anna Maria Heikkinen, Professor

    Wellbeing Services of County Pirkanmaa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mikko Kylmänen, Master of Health Care

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Data will be collected using individual study codes for participants. Study codes do not reveal which group the participant has belonged to.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical study on a medical device.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2024

First Posted

July 3, 2024

Study Start

January 23, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2028

Last Updated

August 6, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations